Award-winning Kenyan singer Nikita Kering has revealed that she was diagnosed with Polycystic Ovary Syndrome (PCOS) six years ago, opening up about her experience living with a condition whose effects are not always visible.
The singer shared the revelation on Thursday, September 3, 2026, as she reflected on the six years since her diagnosis. Nikita used the milestone to celebrate her resilience while extending her support to women living with PCOS and endometriosis.
“It’s now been 6 years with PCOS. So proud of myself and all the strong endometriosis & PCOS girlies out there!” she wrote.
Nikita’s revelation comes as she marks six years of living with PCOS, a hormonal and metabolic condition that can affect ovulation, menstrual cycles, skin, hair, metabolism and fertility.
The singer did not disclose the circumstances surrounding her diagnosis or provide details about the treatment she has received over the six years.
“Living with something people can’t always see takes a lot of strength,” Nikita said.
PCOS can present differently from one person to another. Common features can include irregular or absent periods, signs of elevated androgen levels and difficulties with ovulation. Some women may also experience acne, excess facial or body hair and changes in weight.
The condition can also affect fertility because irregular ovulation can make conception more difficult for some women, although a PCOS diagnosis does not mean pregnancy is impossible.
Alongside revealing her own diagnosis, Nikita used the opportunity to acknowledge other women navigating PCOS and endometriosis.
The singer described them as strong and expressed pride in the resilience they demonstrate while dealing with conditions that can have significant physical and emotional effects.
She also called for greater understanding and support for women dealing with such health challenges.
“I hope you all get the care, support and understanding you deserve,” she said.
Nikita’s message comes at a time when conversations around women’s hormonal and reproductive health continue to gain visibility.
Polycystic Ovary Syndrome, commonly known as PCOS, is a hormonal condition affecting the way the ovaries function.
Despite its name, the presence of ovarian cysts is not necessary for a person to be diagnosed with the condition.
Medical professionals typically assess a combination of features, including irregular ovulation, elevated androgen levels and polycystic ovarian morphology, while ruling out other possible causes.
The condition can also be associated with insulin resistance and an increased risk of some longer-term metabolic conditions.
There is no single treatment that works for everyone with PCOS. Management depends on an individual’s symptoms, health needs and goals and can involve lifestyle changes, medication or treatment aimed at specific symptoms.
Nikita’s disclosure also comes months after an international medical effort gave PCOS a new name.
In May 2026, the condition was renamed polyendocrine metabolic ovarian syndrome (PMOS) following an international consensus process involving medical professionals, researchers and people with lived experience.
The change was intended to better reflect the condition’s hormonal and metabolic characteristics and address the misconception created by the word “polycystic.” The diagnostic criteria and treatment approaches did not change as a result of the renaming.
